全程化药学监护对风湿免疫病患者用药依从性的影响

Impact of Full Course Pharmaceutical Care on the Compliance of Patients with Rheumatic Immune Disease

目的探讨全程化药学监护对风湿免疫病患者用药依从性的影响,分析影响依从性的因素。方法从2017年5月开始对风湿免疫科患者进行全程化药学监护,并利用Morisky量表分别对2017年4月和2017年12月出院患者进行依从性调研,通过SPSS18.0版软件统计分析影响依从性的危险因素。结果接受全程化药学监护之后,出院患者中依从性好的患者比例从57.1%上升到82.1%。依从性与性别、年龄、药品种类无显著相关性,与学历水平呈正相关。40.5%患者由于好转而停药,18.9%患者由于害怕不良反应停药。结论临床药师可以通过全程化药学监护,提高患者对疾病和药物的理解程度,从而提高患者的依从性,这一过程需要药师根据患者的教育背景设计个体化的用药教育方案。

Objective To explore the influence of full course pharmaceutical care on the compliance of patients with rheumatic immune disease,and to analyze the influencing factors.Methods Patients in rheumatology and immunology department were given the full course pharmaceutical care from May 2017.Morisky scale was used to investigate the compliance of patients discharged from the hospital in April 2017 and December 2017,respectively.Risk factors affecting compliance were analyzed by the SPSS 18.0 statistic software.Results It was demonstrated that the proportion of patients with good compliance increased from 57.1%to 82.1%after receiving whole course pharmaceutical care.The compliance was positively correlated with the education background.There was no significant correlation between compliance and gender,age or types of medication.Among the non-compliance patients,40.5%of the patients stopped medication because of improvement,and 18.9%of the patients stopped medication because of the fear of adverse effect.Conclusion Through the full course pharmaceutical care,clinical pharmacists could improve patients'understanding on diseases and drugs,so as to improve patients'compliance.In this process,pharmacists need to design individualized drug education programs according to patients'education background.